
Veeva Vault CTMS Launches at Bristol Myers Squibb
Updated CTMS streamlines trial management to speed medicines to patients.
Veeva Systems announced that Bristol Myers Squibb has implemented Veeva Vault CTMS globally to drive end-to-end trial management. The new CTMS replaced a heritage Celgene CTMS and a heritage Bristol Myers Squibb CTMS and is tightly integrated with Veeva’s eTMF and Study Startup applications. The total implementation time was less than 20 months.
Read more about the launch
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.